Abstract:Enantiomeric separation of chiral pharmaceuticals was carried out by means of in capillary liquid chromatography (CLC) and pressurized capillary electrochromatography (pCEC) using a vancomycin chiral stationary phase (CSP). A 100 microm I.D. fused-silica capillary was packed with 5 microm diameter silica particles modified with vancomycin. Enantiomeric resolution of fifteen beta3-receptor blockers and analogs was studied by polar organic CLC mode and reversed-phase pCEC mode using mobile phases containing methanol-isopropanol-acetic acid-triethylamine and TEAA buffer-methanol, respectively. Several factors affecting chiral separation were investigated in both CLC and pCEC mode. Good enantiomeric resolution was achieved by CLC mode for propranolol, celiprolol, esmolol, bisoprolol, atenolol, metoprolol and carteolol using methanol-isopropanol-acetic acid-triethylamine (70:30:0.05:0.05, v/v/v/v) as mobile phase and for clenbuterol, bambuterol, terbutaline, and salbutamol using methanol-isopropanol-acetic acid-triethylamine (50:50:0.05:005 or 50:50: 0.025:0.05, v/v/v/v) as mobile phase. The baseline was achieved by pCEC mode for the separation of esmolol, bisoprolol, atenolol, metoprolol, carteolol in the mobile phase containing MeOH-0.05%TEAA (pH 7.0) (90:10, v/v) (-10 kV), and that of propranolol and celiprolol in the mobile phase containing MeOH-0.025%TEAA (pH 7.0) (90:10, v/v)(-10 kV). Comparative enantioseparations performed in polar organic CLC and reversed phase pCEC mode revealed significant difference.

[Enatiomeric Separation of Beta-Blocking Agents and Analogs]

Progress in the Enantioseparation of -Blockers by Chromatographic Methods

Enantioseparation of Five Racemic N‐alkyl Drugs by Reverse Phase HPLC Using Sulfobutylether‐β‐cyclodextrin As a Chiral Mobile Phase Additive

Stereoselective Separation of Β-Adrenergic Blocking Agents Containing Two Chiral Centers by Countercurrent Chromatography.

Analytical enantioseparation of N-alkyl drugs by reversed-phase liquid chromatography with carboxymethyl--cyclodextrin as mobile phase additive

Progress in the Enantioseparation of Β-Blockers by Chromatographic Methods

Separation of Beta-Receptor Blockers and Analogs by Capillary Liquid Chromatography (clc) and Pressurized Capillary Electrochromatography (pcec) Using A Vancomycin Chiral Stationary Phase Column

Comparison of the Performance of Chiral Stationary Phase for Separation of Fluoxetine Enantiomers

Enantioseparation Of Etodolac And Its Intermediate On Chiral Stationary Phase By High Pherformance Liquid Chromatography

Enantiomeric Separation of Β-Blockers by HPLC Using (R)-1-naphthylglycine and 3,5-Dinitrobenzoic Acid As Chiral Stationary Phase

Chiral separation of propranolol hydrochloride through an SNM process integrated with crystallization

Chiral separation of propranolol hydrochloride by smb process integrated with crystallization

Separation Of Terfenadine Enantiomers By High Performance Liquid Chromatography Using Beta-Cyclodextrin As Chiral Mobile Phase Additive

Chiral Separation Of Bisoprolol, Atenolol, Clenteral And Terbutaline By Capillary Chromatography

Enantioseparation of 2-(Substituted Phenyl)propanoic Acids by High-Speed Countercurrent Chromatography and Investigation of the Influence of Substituents in Enantiorecognition.

The separation of β-adrenoceptor antagonist enantiomers on Chiralcel(R) OD column

Enantioseparation of Benazepril Intermediates by High‐Performance Liquid Chromatography on Chiral CDMPC Column

Diastereomeric and Enantiomeric High-Performance Liquid Chromatographic Separation of Synthetic Anisodamine

Enantioseparation of Three Non-Steroidal Anti-Inflammatory Agents on Chiral Stationary Phase by HPLC

Enantiomeric separation of 2-arylpropionic acid nonsteroidal anti-inflammatory drugs and β-blockers by RP-HPLC using an amylose chiral stationary phase for the enantioselective skin permeation study

Enantioseparation of 3-phenyllactic acid by chiral ligand exchange countercurrent chromatography.